In vitro and in vivo effects of ribavirin on human respiratory epithelium.
Open Access
- 1 February 1990
- Vol. 45 (2) , 100-104
- https://doi.org/10.1136/thx.45.2.100
Abstract
The effects of ribavirin, a broad spectrum antiviral agent, on the structure and function of normal human nasal epithelium have been studied in vitro, as has also the in vivo effect of treatment with nebulised ribavirin on nasal mucociliary clearance of saccharin in four patients. Ciliary beat frequency was measured by a photometric technique, and changes in epithelial and ciliary ultrastructure were assessed by transmission electron microscopy. Ribavirin solution at the recommended concentration of 20 mg/ml had no adverse effects on ciliary activity in vitro; at concentrations of 50 mg/ml and above it slowed ciliary beating significantly and at 60 mg/ml caused ciliostasis associated with epithelial disruption. Nasal inhalation of ribavirin at 60 mg/ml for up to 20 minutes, however, did not slow nasal mucociliary clearance, nor did it adversely affect the ciliary beating or structure of nasal ciliated epithelium examined in vitro immediately after inhalation.This publication has 22 references indexed in Scilit:
- Ribavirin aerosol for acute bronchiolitis.Archives of Disease in Childhood, 1986
- Beat frequency of cilia from sites of purulent infection.Thorax, 1986
- Lassa FeverNew England Journal of Medicine, 1986
- RIBAVIRIN SUPPRESSES REPLICATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS IN CULTURES OF HUMAN ADULT T LYMPHOCYTESThe Lancet, 1984
- Treatment of influenza A (H1N1) virus infection with ribavirin aerosolAntimicrobial Agents and Chemotherapy, 1984
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983
- Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline.BMJ, 1981
- RIBAVIRIN SMALL-PARTICLE AEROSOL TREATMENT OF INFLUENZAThe Lancet, 1981
- NON-INVASIVE SAMPLING OF NASAL CILIA FOR MEASUREMENT OF BEAT FREQUENCY AND STUDY OF ULTRASTRUCTUREThe Lancet, 1980
- In Vitro Effect of 1-β- d -Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Deoxyribonucleic Acid and Ribonucleic Acid VirusesAntimicrobial Agents and Chemotherapy, 1973